SINTX TECHNOLOGIES INC (SINT)
US8293926049 - Common Stock
Overall SINT gets a fundamental rating of 3 out of 10. We evaluated SINT against 192 industry peers in the Health Care Equipment & Supplies industry. The financial health of SINT is average, but there are quite some concerns on its profitability. SINT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SINT had negative earnings in the past year.
In the past year SINT has reported a negative cash flow from operations.
SINT had negative earnings in each of the past 5 years.
In the past 5 years SINT always reported negative operating cash flow.
1.2 Ratios
SINT's Return On Assets of -53.90% is on the low side compared to the rest of the industry. SINT is outperformed by 71.35% of its industry peers.
Looking at the Return On Equity, with a value of -94.40%, SINT is doing worse than 68.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.9% | ||
| ROE | -94.4% | ||
| ROIC | N/A |
ROA(3y)-67.04%
ROA(5y)-67.51%
ROE(3y)-145.96%
ROE(5y)-129.28%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of SINT (69.79%) is better than 80.73% of its industry peers.
In the last couple of years the Gross Margin of SINT has grown nicely.
The Profit Margin and Operating Margin are not available for SINT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.79% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y51.09%
GM growth 5Y11.89%
2. Health
2.1 Basic Checks
SINT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SINT has more shares outstanding
SINT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SINT has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -26.94, we must say that SINT is in the distress zone and has some risk of bankruptcy.
SINT has a worse Altman-Z score (-26.94) than 90.63% of its industry peers.
There is no outstanding debt for SINT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -26.94 |
ROIC/WACCN/A
WACC10.01%
2.3 Liquidity
SINT has a Current Ratio of 1.90. This is a normal value and indicates that SINT is financially healthy and should not expect problems in meeting its short term obligations.
SINT has a worse Current ratio (1.90) than 75.52% of its industry peers.
SINT has a Quick Ratio of 1.60. This is a normal value and indicates that SINT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of SINT (1.60) is worse than 68.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.6 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 94.65% over the past year.
Looking at the last year, SINT shows a very strong growth in Revenue. The Revenue has grown by 67.64%.
Measured over the past years, SINT shows a very strong growth in Revenue. The Revenue has been growing by 92.26% on average per year.
EPS 1Y (TTM)94.65%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q98.88%
Revenue 1Y (TTM)67.64%
Revenue growth 3Y64.51%
Revenue growth 5Y92.26%
Revenue growth Q2Q17.14%
3.2 Future
The Earnings Per Share is expected to grow by 26.93% on average over the next years. This is a very strong growth
Based on estimates for the next years, SINT will show a quite strong growth in Revenue. The Revenue will grow by 11.53% on average per year.
EPS Next Y33.36%
EPS Next 2Y26.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year46.24%
Revenue Next 2Y11.53%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SINT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SINT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SINT's earnings are expected to grow with 26.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.93%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for SINT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SINTX TECHNOLOGIES INC
NASDAQ:SINT (5/2/2024, 11:01:59 AM)
0.0459
0 (-1.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.34M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -53.9% | ||
| ROE | -94.4% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 69.79% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.6 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)94.65%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y33.36%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)67.64%
Revenue growth 3Y64.51%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y